MTSR - Metsera Inc.
70.5
-0.250 -0.355%
Share volume: 27,908,901
Last Updated: 11-13-2025
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$70.75
-0.25
0.00%
View ratios
| Fiscal Date | 03-31-2025 | 06-30-2025 | |
|---|---|---|---|
| Fiscal Quarter | Q1 2025 | Q2 2025 | |
| Report Date | 05-12-2025 | 07-28-2025 | |
| Total revenue | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | |
| nan% | |||
| Operating expenses | 65.788 M | 71.993 M | |
| Selling general and admin | 8.603 M | 11.482 M | |
| Research and development | 57.185 M | 60.511 M | |
| Total expenses | 79.808 M | 71.123 M | |
| -10.88% | |||
| Operating income | -79.808 M | -71.123 M | |
| Ebit | -81.398 M | -74.081 M | |
| Pretax income | -76.588 M | -68.715 M | |
| -10.28% | |||
| Income tax | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | |
| Net income | -76.588 M | -68.715 M | |
| 10.28% |